IRON FY2025 SEC EDGAR DEF 14A #133 of 168 in industry

Disc Medicine, Inc. CEO pay ratio

The CEO earned $10.3M in FY2025 against median worker pay of $570,211 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
MA
Filing date
2026-04-28
Industry
Chemicals & Pharmaceuticals
Industry rank
#133/168

Data updated August 2026

Subscribe to Disc Medicine, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
18:1
Below Average (Scale: 0–1000:1)
CEO pay
$10.3M
Median worker
$570,211

Answer first

Disc Medicine, Inc.'s FY2025 CEO total of $10.3M ranks #511 of 1,423 complete filings; its 18:1 pay ratio ranks #1229. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $570,211. Industry placement uses the FY2025 SIC-28 peer cohort (# 133 of 168, 21st percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#511
$10.3M of 1,423 FY2025
Ratio rank
#1229
18:1 of 1,423
Industry pct
21st
among the lower quartile of industry peers by pay ratio

How Disc Medicine, Inc. ranks nationally

Disc Medicine, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$10,263,798 Top 36% higher than 64% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). This entry sits in this band. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Disc Medicine, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($10.3M) against pay ratio (18:1) for Disc Medicine, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02690243.95380487.88070731.710760975.615.8:122.6:129.5:136.4:143.3:1CEO total payPay ratio (CEO : median worker)Disc Medicine, Inc., CEO total pay: 10263798 · Pay ratio (CEO : median worker): 18:1Disc Medicine, Inc.Agios Pharmaceuticals, Inc., CEO total pay: 5456520 · Pay ratio (CEO : median worker): 18:1Agios Pharmaceuticals, Inc.Aurinia Pharmaceuticals Inc., CEO total pay: 320246 · Pay ratio (CEO : median worker): 18:1Aurinia Pharmaceuticals Inc.Syndax Pharmaceuticals Inc, CEO total pay: 7281788 · Pay ratio (CEO : median worker): 19:1Syndax Pharmaceuticals IncuniQure N.V., CEO total pay: 3287434 · Pay ratio (CEO : median worker): 19:1uniQure N.V.Intellia Therapeutics, Inc., CEO total pay: 5117748 · Pay ratio (CEO : median worker): 17:1Intellia Therapeutics, Inc.
Disc Medicine, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Disc Medicine, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Disc Medicine, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2024–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
18:1
FY2025
vs prior FY
-2:1
from FY2024 20:1
CEO $ YoY
+14%
$10.3M latest
Filings shown
2
FY2024–2025
Disc Medicine, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2024 $9.0M - $451,886 20:1 -
2025 $10.3M +14% $570,211 18:1 -2:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1816736, FY2024–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
18:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$10.3M
Companies in Industry
168
vs. Industry Median
Below
#133 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Disc Medicine, Inc.: near-parity Item 402(u) ratio

Disc Medicine, Inc.'s FY2025 ratio 18:1 ranks #133 of 168 Chemicals & Pharmaceuticals filers (21st percentile). the CEO earned 18× the median employee ($570,211) in FY2025.

At $570,211 median worker pay, the FLOOR stamp is near pay-parity territory under HEAVY CEO total.

CEO Total Pay

$10.3M

FY2025 Summary Compensation, above median

Pay Ratio

18:1

Below typical

Disc Medicine, Inc. in the lower Chemicals & Pharmaceuticals third

Disc Medicine, Inc.'s FY2025 ratio 18:1 ranks #133 of 168 Chemicals & Pharmaceuticals filers (21st percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Disc Medicine, Inc.'s $10.3M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #511 and ratio rank #1229 split - treat 18:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$10.3M
Median Employee Pay
$570,211
Pay Ratio
18:1
Filing Date
2026-04-28

Company Info

Ticker
IRON
CIK
1816736
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
MA
View SEC filings →
SEC EDGAR DEF 14A for CIK 1816736, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Disc Medicine, Inc.'s FY2025 ratio 18:1 ranks #133 of 168 Chemicals & Pharmaceuticals filers (21st percentile).

Read with Disc Medicine, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · HEAVY · ELITE-MED.

Yelp Inc · HEAVY

ABS(ceo_total_comp) peer at $10.3M (Δ $7K lighter vs Disc Medicine, Inc.); MID · HIGH-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Ani Pharmaceuticals Inc · HEAVY

ABS(ceo_total_comp) peer at $10.3M (Δ $9K lighter vs Disc Medicine, Inc.); MID · HIGH-MED vs this page's FLOOR · HEAVY · ELITE-MED.
AdaptHealth Corp. · HEAVY

ABS(ceo_total_comp) peer at $10.2M (Δ $15K lighter vs Disc Medicine, Inc.); STEEP · PAR-MED vs this page's FLOOR · HEAVY · ELITE-MED.
First Citizens Bancshares Inc /de/ · HEAVY

ABS(ceo_total_comp) peer at $10.2M (Δ $16K lighter vs Disc Medicine, Inc.); MID · ELITE-MED vs this page's FLOOR · HEAVY · ELITE-MED.
Agios Pharmaceuticals, Inc. (SIC 28 pole)

Agios Pharmaceuticals, Inc. stamps FLOOR · MID$ nearest in-SIC by ABS(pay_ratio) to Disc Medicine, Inc.'s FLOOR filing.
National dual ranks · #511/#1229

Disc Medicine, Inc.'s FY2025 package sits #511 by CEO dollars and #1229 by ratio under HEAVY · FLOOR.
Ratio primer · FLOOR

Disc Medicine, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Disc Medicine, Inc. (CIK 1816736), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.